Ardelyx's constipation drug succeeds in late-stage trial

loading...


Ardelyx’s constipation drug succeeds in late-stage trial
(Reuters) – Ardelyx Inc said a second late-stage trial of its drug for irritable bowel syndrome with constipation (IBS-C) met the main goal of reducing abdominal pain and increasing bowel movement, sending its shares up sharply in extended trading.


Source: Health And Fitness

Reply

Pin It on Pinterest

Shares
Share This
loading...